// App-Quantinova.ai

: ‘The efficiency of the treatment by Sandostatin-Lar in patients with non-functional pituitary macroadenomas’

Researchers

Presenter

  • Malika Mirtukhtaeva

Principal Investigators

  • Ashley Grossman

  • Nitin Leekha

  • Alisher Akbutaev

  • Urmanova Yulduz

Medical Centers

  • Republican Specialized Scientific Practical Medical Center of Endocrinology of Republic of Uzbekistan named by Ya.Kh.Turakulov, Tashkent, Uzbekistan

  • University of Oxford Senior Research Fellow, Green Templeton College, United Kingdom

  • Jaypee Hospital, Sector 128, Noida, India, Oncology Department, Noida, India

  • Republican Specialized Scientific Practical Medical Center of Endocrinology of Public Health Ministry named by acad. Ya.Kh. Turakulov, Department of Neurendocrinology, Tashkent, Uzbekistan

  • Tashkent Pediatric Medical Institute, Department of Endocrinology Children Endocrinology, Tashkent, Uzbekistan

Locations

  • Uzbekistan

  • United Kingdom

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pituitary adenomas

Biomarkers

  • Adrenocorticotropic hormone

  • Prolactin

  • Follicle-stimulating hormone

  • Insulin-like growth factor 1

  • Triglyceride Level

Drug/Treatment

  • Octreotide acetate

  • Mecasermin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A